[1]刘良友,杨涛,丛小虎,等. 两套商用治疗计划系统中VMAT计划质量及其验证的对比研究[J].中国医学物理学杂志,2018,35(11):1241-1245.[doi:DOI:10.3969/j.issn.1005-202X.2018.11.001]
　LIU Liangyou,YANG Tao,CONG Xiaohu,et al. Comparison on plan quality and dose verification of volumetric modulated arc therapy plans designed by two commercial planning systems[J].Chinese Journal of Medical Physics,2018,35(11):1241-1245.[doi:DOI:10.3969/j.issn.1005-202X.2018.11.001]
点击复制

 两套商用治疗计划系统中VMAT计划质量及其验证的对比研究()
分享到：

《中国医学物理学杂志》[ISSN:1005-202X/CN:44-1351/R]

卷:
35卷
期数:
2018年第11期
页码:
1241-1245
栏目:
医学放射物理
出版日期:
2018-11-18

文章信息/Info

Title:
 Comparison on plan quality and dose verification of volumetric modulated arc therapy plans designed by two commercial planning systems
文章编号:
1005-202X（2018）11-1241-05
作者:
 刘良友; 杨涛; 丛小虎; 王小深; 王金媛; 刘梦雯; 徐寿平
 解放军总医院放疗科， 北京 100853
Author(s):
 LIU Liangyou;  YANG Tao;  CONG Xiaohu;  WANG Xiaoshen;  WANG Jinyuan;  LIU Mengwen;  XU Shouping
 Department of Radiation Oncology, Chinese PLA General Hospital, Beijing 100853, China
关键词:
 ; 容积旋转调强放疗; 喉癌; 直肠癌; 计划质量; 剂量验证; 治疗计划系统
Keywords:
 ; Keywords: volumetric intensity modulated arc therapy;  laryngeal cancer;  rectal cancer;  plan quality;  dose verification;  treatment planning system
分类号:
R312；R811.1
DOI:
DOI:10.3969/j.issn.1005-202X.2018.11.001
文献标志码:
A
摘要:
 目的：探讨两套商用治疗计划系统（TPS）用于喉癌与直肠癌患者容积旋转调强放疗（VMAT）的剂量学特性与验证结果差异，为其临床应用提供一定的依据。 方法：选取喉癌患者10例、直肠癌患者12例，分别利用Eclipse和Pinnacle商用TPS进行VMAT及其验证计划设计，利用ArcCheck实施剂量数据的采集，分析标准为3%/3 mm和2%/2 mm条件下Gamma通过率。从计划质量、实施效率、验证结果等方面评价两套系统执行VMAT技术的差异性。 结果：计划质量方面：喉癌VMAT计划中，Eclipse在危及器官保护以及计划靶区（PTV）的适形度指数（CI）、均匀性指数（HI）上与 Pinnacle相近（P>0.05），Eclipse的MU要少于Pinnacle，但无统计学差异（P>0.05）；直肠癌VMAT计划中，Eclipse在MU、PTV的CI和HI以及对膀胱、小肠的保护上与Pinnacle相近，在左右股骨头的V40上，Eclipse略优于Pinnacle，但无统计学差异（P>0.05）。剂量验证方面：无论是喉癌还是直肠癌VMAT计划，在分析评价标准3%/3 mm和2%/2 mm条件下，Eclipse的Gamma通过率均高于Pinnacle，且均具有统计学差异（P<0.05）。 结论：尽管两套TPS的喉癌和直肠癌VMAT计划质量相近，且剂量验证均能满足临床治疗的要求，但两套计划系统在MU以及剂量验证通过率上存在一定的差异性，仍需选择更多的病例进一步探讨以确定其差异的原因。
Abstract:
 Abstract: Objective To investigate the differences in dosimetric characteristics and dose verification of volumetric modulated arc therapy (VMAT) plans designed by two commercial planning systems for patients with laryngeal and rectal cancers for providing some guidance for the clinical application of treatment planning system. Methods VMAT plans and verification plans based on Eclipse and Pinnacle were designed for 10 patients with laryngeal cancer and 12 patients with rectal cancer. ArcCheck system was used for data collection and Gamma passing rates were analyzed with the criteria of 3%/3 mm and 2%/2 mm. The plan quality, delivery efficiency and dose verification were analyzed to discuss the differences between VMAT plans based on two different planning systems. Results For patients with laryngeal cancer, the protection of organs-at-risk, the conformity index and homogeneity index of planning target area in VMAT plans based on Eclipse were similar to those in VMAT plans based on Pinnacle (P>0.05), but the monitor unit of VMAT plans based on Eclipse was less than that of VMAT plans based on Pinnacle, without statistical differences (P>0.05). For patients with rectal cancer, the monitor units, the conformity index and homogeneity index of planning target area were similar between VMAT plans based on Eclipse and VMAT plans based on Pinnacle, so was the protection of bladder and small intestine. However, the V40 of femur-L and femur-R in VMAT plans based on Eclipse for rectal cancer were superior to that in VMAT plans based on Pinnacle, without statistical differences (P>0.05). Under the criteria of 3%/3 mm and 2%/2 mm, the Gamma passing rates of VMAT plans based on Eclipse were higher than those of VMAT plans based on Pinnacle for laryngeal and rectal cancers, and the differences were statistically significant (P<0.05). Conclusion Although the plan quality and dose verification of VMAT plans based on Eclipse and Pinnacle can satisfy the requirements of clinical treatment, there is a slight difference in the passing rates of dose verification and monitor units. Further investigations should be conducted in more cases to explore the reasons for the differences.

相似文献/References:

[1]陈广涛,汪 淇,刘亚强,等.TrueBeam加速器射野准直器跟随功能在鼻咽癌固定野调强放疗和容积旋转调强放疗中的应用[J].中国医学物理学杂志,2014,31(03):4865.[doi:10.3969/j.issn.1005-202X.2014.03.005]
[2]刘清智,蒋华勇,许卫东,等.胸膜间皮瘤螺旋断层调强放疗和容积旋转调强放疗的剂量学评估[J].中国医学物理学杂志,2015,32(05):690.[doi:doi:10.3969/j.issn.1005-202X.2015.05.017]
　[J].Chinese Journal of Medical Physics,2015,32(11):690.[doi:doi:10.3969/j.issn.1005-202X.2015.05.017]
[3]张富利,蒋华勇,许卫东,等.基于不同多叶准直器的胸膜间皮瘤容积旋转调强放疗剂量学比较[J].中国医学物理学杂志,2015,32(05):635.[doi:doi:10.3969/j.issn.1005-202X.2015.05.005]
[4]王遥,霍万里,熊壮,等.TACE手术中不同站姿下铅眼镜和铅面罩对医生眼晶状体防护效果的蒙特卡洛模拟比较[J].中国医学物理学杂志,2016,33(6):553.[doi:DOI:10.3969/j.issn.1005-202X.2016.06.003]
　[J].Chinese Journal of Medical Physics,2016,33(11):553.[doi:DOI:10.3969/j.issn.1005-202X.2016.06.003]
[5]张新,谷晓芳,王培臣,等.轻离子束治疗设备注册检验关键技术问题[J].中国医学物理学杂志,2016,33(6):559.[doi:10.3969/j.issn.1005-202X.2016.06.004]
　[J].Chinese Journal of Medical Physics,2016,33(11):559.[doi:10.3969/j.issn.1005-202X.2016.06.004]
[6]江芬芬,王培,康盛伟,等. 热释光剂量片测量肺部肿瘤放疗剂量的方法[J].中国医学物理学杂志,2016,33(6):564.[doi:10.3969/j.issn.1005-202X.2016.06.005]
　[J].Chinese Journal of Medical Physics,2016,33(11):564.[doi:10.3969/j.issn.1005-202X.2016.06.005]
[7]刘洪源,彭威,杨锐,等. 锥形束CT离线校正肺癌摆位误差[J].中国医学物理学杂志,2016,33(6):573.[doi:10.3969/j.issn.1005-202X.2016.06.007]
　[J].Chinese Journal of Medical Physics,2016,33(11):573.[doi:10.3969/j.issn.1005-202X.2016.06.007]
[8]赵彪,潘香,杨毅,等. 右乳癌保乳术后瘤床同步X线和后程电子线补量调强放疗剂量学比较[J].中国医学物理学杂志,2016,33(6):576.[doi:10.3969/j.issn.1005-202X.2016.06.008]
　[J].Chinese Journal of Medical Physics,2016,33(11):576.[doi:10.3969/j.issn.1005-202X.2016.06.008]
[9]邓南,钱建庭,刁现芬,等. 基于宽带检测放疗X-光光声效应仿体实验[J].中国医学物理学杂志,2016,33(9):865.[doi:DOI:10.3969/j.issn.1005-202X.2016.09.001]
　[J].Chinese Journal of Medical Physics,2016,33(11):865.[doi:DOI:10.3969/j.issn.1005-202X.2016.09.001]
[10]张先稳,李军,张西志,等. 宫颈癌术后5野调强放疗4个变量组合的最佳治疗模式的剂量学[J].中国医学物理学杂志,2016,33(9):872.[doi:10.3969/j.issn.1005-202X.2016.09.002]
　[J].Chinese Journal of Medical Physics,2016,33(11):872.[doi:10.3969/j.issn.1005-202X.2016.09.002]
[11]杨思原,张季,潘香,等. 左乳癌保乳术后瘤床同步加量静态调强和容积旋转调强的剂量学研究[J].中国医学物理学杂志,2017,34(9):874.[doi:DOI:10.3969/j.issn.1005-202X.2017.09.003]
　[J].Chinese Journal of Medical Physics,2017,34(11):874.[doi:DOI:10.3969/j.issn.1005-202X.2017.09.003]
[12]王占宇,谭军文,龙雨松,等. 非均整与均整模式下宫颈癌容积旋转调强放疗计划的剂量学比较[J].中国医学物理学杂志,2017,34(11):1110.[doi:DOI:10.3969/j.issn.1005-202X.2017.11.007]
　WANG Zhanyu,TAN Junwen,LONG Yusong,et al. Dosimetric comparison of VMAT plans in different modes for cervical cancer: flatting filter free vs flattening filter[J].Chinese Journal of Medical Physics,2017,34(11):1110.[doi:DOI:10.3969/j.issn.1005-202X.2017.11.007]
[13]左宇浩,杨振,周剑良,等. 基于广义等效均匀剂量优化的直肠癌计划在固定野和容积旋转调强放疗中的比较[J].中国医学物理学杂志,2018,35(2):171.[doi:DOI:10.3969/j.issn.1005-202X.2018.02.010]
　ZUO Yuhao,YANG Zhen,ZHOU Jianliang,et al. Comparison of different plans based on generalized equivalent uniform dose optimization for rectal cancer: fixed-field intensity-modulated radiotherapy vs volumetric modulated arc therapy[J].Chinese Journal of Medical Physics,2018,35(11):171.[doi:DOI:10.3969/j.issn.1005-202X.2018.02.010]
[14]龙雨松,谭军文,贺先桃,等. 肺癌固定剂量率旋转调强和容积旋转调强的剂量学分析[J].中国医学物理学杂志,2018,35(2):176.[doi:DOI:10.3969/j.issn.1005-202X.2018.02.011]
　LONG Yusong,TAN Junwen,HE Xiantao,et al. Dosimetric analysis of intensity-modulated arc radiotherapy with fixed dose rate versus volumetric modulated arc therapy for lung cancer[J].Chinese Journal of Medical Physics,2018,35(11):176.[doi:DOI:10.3969/j.issn.1005-202X.2018.02.011]
[15]蔡俊涛,陈凡,王财,等. 非小细胞肺癌容积旋转调强与适形调强放疗的剂量学比较[J].中国医学物理学杂志,2018,35(4):389.[doi:DOI:10.3969/j.issn.1005-202X.2018.04.004]
　CAI Juntao,CHEN Fan,WANG Cai,et al. Dosimetric comparison of volumetric modulated arc therapy and intensity-modulated radiotherapy for non-small cell lung cancer[J].Chinese Journal of Medical Physics,2018,35(11):389.[doi:DOI:10.3969/j.issn.1005-202X.2018.04.004]

备注/Memo

备注/Memo:
 【收稿日期】2018-06-11
【基金项目】国家重点研发专项项目（2017YFC0112105）；国家自然科学基金青年科学基金（61601012）
【作者简介】刘良友，物理师，研究方向：医学物理，E-mail: 15901113022@163.com
【通信作者】徐寿平，高级工程师，研究方向：肿瘤放射物理与精确放疗，E-mail: shoupingxu@yahoo.com
更新日期/Last Update: 2018-11-22